Get the Stockscreener App
259.65
1.61%
-4.25
First Trust Nyse Arca Biotechnology Index Fund Stock (FBT) Forecast
The First Trust Nyse Arca Biotechnology Index Fund (FBT) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $258.11, representing a -0.59% decrease from the current price of $259.65. The highest analyst price target is $265.42, and the lowest is $250.81.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month FBT Price Target
Average 244.71
(-5.75% Downside)
Is First Trust Nyse Arca Biotechnology Index Fund (FBT) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 41.69 | Neutral |
| STOCH(9,6) | 27.49 | Neutral |
| STOCHRSI(14) | 4.5827 | Buy |
| MACD(12,26) | -0.875 | Sell |
| ADX(14) | 16.26 | Neutral |
| William %R | -80.35 | Buy |
| CCI(14) | -99.48 | Neutral |
Buy: 2
Sell: 1
Neutral: 4
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
265.30
Sell
|
264.75
Sell
|
| MA20 |
268.11
Sell
|
266.17
Sell
|
| MA50 |
265.43
Sell
|
262.72
Sell
|
| MA100 |
251.31
Buy
|
251.79
Buy
|
| MA200 |
229.14
Buy
|
233.21
Buy
|
Buy: 4
Sell: 6
Neutral: 0
Summary: Sell
According to our latest analysis, FBT could be considered a Moderate Sell, with 17 technical analysis indicators signaling 6 Buy signals, 7 signaling Sell signals and 4 Neutral signals. This might not be a good time to consider opening new positions on FBT, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 41.69 indicates that FBT is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 27.49 indicates that FBT is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 4.5827 indicates that FBT is oversold. This suggests that FBT price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 16.26 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -99.48 indicates that FBT is still oversold but not to an extreme extent.
Long-term FBT price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about First Trust Nyse Arca Biotechnology Index Fund financial reports and earnings history, First Trust Nyse Arca Biotechnology Index Fund (FBT) stock could reach $298.95 by 2030, $501.08 by 2040 and $658.65 by 2050. See the projected annual prices until 2050 of the First Trust Nyse Arca Biotechnology Index Fund stock below:
- First Trust Nyse Arca Biotechnology Index Fund (FBT) is expected to reach an average price of $389.06 in 2035, with a high prediction of $400.06 and a low estimate of $388.78. This indicates an $49.84% rise from the last recorded price of $259.65.
- First Trust Nyse Arca Biotechnology Index Fund (FBT) stock is projected to chart a bullish course in 2040, with an average price target of $493.93, representing an $90.23% surge from its current level. The forecast ranges from a conservative $490.73 to a sky-high $501.08.
- Our analysts predict First Trust Nyse Arca Biotechnology Index Fund (FBT) to jump 123.84% by 2045, soaring from $567.55 to an average price of $581.20, potentially reaching $582.66. While $567.55 is the low estimate, the potential upside is significant.
- First Trust Nyse Arca Biotechnology Index Fund (FBT) stock is expected to climb by 2050, reaching an average of $646.70, a $149.07% jump from its current level. However, a wide range of estimates exists, with high and low targets of $658.65 and $645.09, respectively, highlighting the market's uncertainty.
First Trust Nyse Arca Biotechnology Index Fund Stock (FBT) Year by Year Forecast
First Trust Nyse Arca Biotechnology Index Fund Stock (FBT) Price Forecast for 2026
The predicted value for First Trust Nyse Arca Biotechnology Index Fund (FBT) in 2026 is set at an average of $232.35. Estimates vary from a peak of $275.23 to a trough of $189.47, indicating an -10.51% surge from the present price of $259.65.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| November, 2026 | $254.78 | $250.81 | $265.42 | -1.88% |
| December, 2026 | $260.36 | $247.30 | $260.89 | +0.27% |
First Trust Nyse Arca Biotechnology Index Fund Stock (FBT) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for First Trust Nyse Arca Biotechnology Index Fund (FBT) is $243.68, with a high forecast of $263.36 and a low forecast of $224.00. This indicates an -6.15% decrease from the last price of $259.65.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $251.63 | $247.47 | $263.36 | -3.09% |
| February, 2027 | $247.20 | $236.48 | $250.06 | -4.80% |
| March, 2027 | $242.71 | $236.60 | $253.07 | -6.52% |
| April, 2027 | $249.06 | $236.18 | $252.06 | -4.08% |
| May, 2027 | $236.61 | $236.27 | $257.49 | -8.87% |
| June, 2027 | $240.16 | $225.64 | $243.20 | -7.50% |
| July, 2027 | $230.25 | $224.00 | $240.19 | -11.32% |
| August, 2027 | $243.26 | $229.80 | $247.31 | -6.31% |
| September, 2027 | $251.89 | $240.32 | $254.24 | -2.99% |
| October, 2027 | $242.34 | $240.06 | $254.05 | -6.67% |
| November, 2027 | $240.18 | $233.98 | $250.94 | -7.50% |
| December, 2027 | $249.82 | $236.91 | $251.27 | -3.79% |
First Trust Nyse Arca Biotechnology Index Fund Stock (FBT) Price Forecast for 2028
In 2028, First Trust Nyse Arca Biotechnology Index Fund (FBT) is projected to reach an average price of $261.59, with a high projection of $275.35 and a low estimate of $247.82. This indicates an +0.75% rise from the last price of $259.65.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $262.92 | $247.82 | $262.93 | +1.26% |
| February, 2028 | $263.17 | $259.70 | $268.31 | +1.36% |
| March, 2028 | $270.23 | $259.13 | $271.87 | +4.08% |
| April, 2028 | $269.06 | $268.15 | $275.35 | +3.62% |
| May, 2028 | $258.38 | $256.72 | $272.49 | -0.49% |
| June, 2028 | $268.71 | $257.97 | $268.79 | +3.49% |
| July, 2028 | $268.39 | $261.25 | $270.85 | +3.37% |
| August, 2028 | $269.67 | $264.68 | $273.82 | +3.86% |
| September, 2028 | $266.74 | $264.10 | $274.63 | +2.73% |
| October, 2028 | $270.33 | $262.88 | $272.60 | +4.11% |
| November, 2028 | $268.55 | $264.53 | $269.53 | +3.43% |
| December, 2028 | $266.94 | $266.89 | $272.07 | +2.81% |
First Trust Nyse Arca Biotechnology Index Fund Stock (FBT) Price Forecast for 2029
The 2029 price forecast for First Trust Nyse Arca Biotechnology Index Fund Stock (FBT) is $271.32 on average, with a high prediction of $295.08 and a low estimate of $247.56. This represents an +4.49% increase from the previous price of $259.65.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $255.32 | $255.32 | $267.26 | -1.67% |
| February, 2029 | $252.86 | $247.56 | $259.13 | -2.61% |
| March, 2029 | $261.87 | $251.60 | $261.87 | +0.86% |
| April, 2029 | $277.23 | $261.73 | $280.74 | +6.77% |
| May, 2029 | $269.00 | $269.00 | $280.09 | +3.60% |
| June, 2029 | $271.61 | $264.89 | $272.49 | +4.60% |
| July, 2029 | $274.91 | $271.18 | $278.35 | +5.88% |
| August, 2029 | $264.15 | $262.83 | $277.33 | +1.73% |
| September, 2029 | $272.19 | $264.15 | $273.88 | +4.83% |
| October, 2029 | $275.38 | $271.20 | $279.58 | +6.06% |
| November, 2029 | $285.34 | $273.33 | $287.41 | +9.89% |
| December, 2029 | $290.58 | $284.42 | $295.08 | +11.91% |
First Trust Nyse Arca Biotechnology Index Fund Stock (FBT) Price Forecast for 2030
First Trust Nyse Arca Biotechnology Index Fund Stock (FBT) is expected to reach an average price of $294.47 in 2030, with a high forecast of $314.57 and a low forecast of $274.38. This signifies an +13.41% surge from the last price of $259.65.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $291.16 | $290.16 | $298.95 | +12.14% |
| February, 2030 | $299.20 | $291.47 | $301.20 | +15.23% |
| March, 2030 | $295.74 | $295.69 | $301.86 | +13.90% |
| April, 2030 | $297.79 | $288.77 | $308.42 | +14.69% |
| May, 2030 | $295.21 | $291.83 | $306.75 | +13.69% |
| June, 2030 | $301.72 | $294.31 | $302.42 | +16.20% |
| July, 2030 | $307.41 | $301.77 | $314.57 | +18.39% |
| August, 2030 | $301.29 | $298.12 | $311.07 | +16.04% |
| September, 2030 | $285.03 | $274.38 | $304.07 | +9.78% |
| October, 2030 | $297.67 | $283.59 | $298.37 | +14.64% |
| November, 2030 | $295.76 | $286.71 | $299.18 | +13.91% |
| December, 2030 | $296.74 | $292.74 | $301.93 | +14.28% |
0.20%
0.02%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):